Correlation Between Jasper Therapeutics and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Jasper Therapeutics and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Jasper Therapeutics and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Jasper Therapeutics and SAB Biotherapeutics, you can compare the effects of market volatilities on Jasper Therapeutics and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Jasper Therapeutics with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Jasper Therapeutics and SAB Biotherapeutics.
Diversification Opportunities for Jasper Therapeutics and SAB Biotherapeutics
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Jasper and SAB is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Jasper Therapeutics and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and Jasper Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Jasper Therapeutics are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of Jasper Therapeutics i.e., Jasper Therapeutics and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between Jasper Therapeutics and SAB Biotherapeutics
Given the investment horizon of 90 days Jasper Therapeutics is expected to under-perform the SAB Biotherapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Jasper Therapeutics is 1.19 times less risky than SAB Biotherapeutics. The stock trades about -0.17 of its potential returns per unit of risk. The SAB Biotherapeutics is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 281.00 in SAB Biotherapeutics on December 2, 2024 and sell it today you would lose (110.00) from holding SAB Biotherapeutics or give up 39.15% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Jasper Therapeutics vs. SAB Biotherapeutics
Performance |
Timeline |
Jasper Therapeutics |
SAB Biotherapeutics |
Jasper Therapeutics and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Jasper Therapeutics and SAB Biotherapeutics
The main advantage of trading using opposite Jasper Therapeutics and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Jasper Therapeutics position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.Jasper Therapeutics vs. Lyra Therapeutics | Jasper Therapeutics vs. Equillium | Jasper Therapeutics vs. Hookipa Pharma | Jasper Therapeutics vs. Acumen Pharmaceuticals |
SAB Biotherapeutics vs. Processa Pharmaceuticals | SAB Biotherapeutics vs. Third Harmonic Bio | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |